CIK 0001623526
- Non-accelerated filer
- Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 471144582
- Phone
- +1 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $403,975
- in 4 filings, $404K under 10b5-1 plans
Net −$403,975. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-02 | Kaye Edward M. MD CEO | Grant or award · Employee Stock Option (Right to Buy) | +200,800 | 200,800 | ||
| 2021-03-01 | LEVIN ARTHUR A Director | Exercise or conversion | +2,776 | $0.40 | $1K | 2,776 |
| 2021-03-01 | LEVIN ARTHUR A Director | Exercise or conversion | +1,842 | $0.40 | $737 | 4,618 |
| 2021-03-01 | LEVIN ARTHUR A Director | Exercise or conversion | +7,882 | $0.60 | $5K | 12,500 |
| 2021-03-01 | LEVIN ARTHUR A Director | Sale | −7,543 | $60.55 | $457K | 4,957 |
| 2021-03-01 | LEVIN ARTHUR A Director | Sale | −4,957 | $61.14 | $303K | 0 |
| 2021-03-01 | LEVIN ARTHUR A Director | Exercise or conversion · Director Stock Option (Right to Buy) | −2,776 | 0 | ||
| 2021-03-01 | LEVIN ARTHUR A Director | Exercise or conversion · Director Stock Option (Right to Buy) | −1,842 | 0 | ||
| 2021-03-01 | LEVIN ARTHUR A Director | Exercise or conversion · Director Stock Option (Right to Buy) | −7,882 | 8,764 | ||
| 2021-02-23 | Tulipano Stephen J CFO | Exercise or conversion | +5,000 | $4.48 | $22K | 5,602 |
| 2021-02-23 | Tulipano Stephen J CFO | Sale | −5,000 | $58.60 | $293K | 602 |
| 2021-02-23 | Tulipano Stephen J CFO | Exercise or conversion · Employee Stock Option (Right to Buy) | −5,000 | 179,997 | ||
| 2021-02-22 | Tulipano Stephen J CFO | Exercise or conversion | +25,000 | $4.48 | $112K | 25,602 |
| 2021-02-22 | Tulipano Stephen J CFO | Sale | −15,202 | $58.67 | $892K | 10,400 |
| 2021-02-22 | Tulipano Stephen J CFO | Sale | −9,696 | $59.29 | $575K | 704 |
| 2021-02-22 | Tulipano Stephen J CFO | Sale | −102 | $60.00 | $6K | 602 |
| 2021-02-22 | Tulipano Stephen J CFO | Exercise or conversion · Employee Stock Option (Right to Buy) | −25,000 | 184,997 | ||
| 2021-02-19 | TZIANABOS ARTHUR Director | Exercise or conversion | +10,000 | $2.19 | $22K | 10,000 |
| 2021-02-19 | TZIANABOS ARTHUR Director | Sale | −10,000 | $60.67 | $607K | 0 |
| 2021-02-19 | TZIANABOS ARTHUR Director | Exercise or conversion · Director Stock Option (Right to Buy) | −10,000 | 13,447 |
Page 25 of 35 · 681 trades